BRITAIN DRUG MERGER, LONDON, United Kingdom England
Sir Richard Sykes, left, Chairman of Glaxo Wellcome, and Jean-Pierre Garnier, Chief Executive officer of SmithKline Beecham shake hands for reporters in Central London, after their announcement of the proposed merger of the two pharmaceutical companies. The new company called Glaxo SmithKline, would hold a 7.3 percent share of the global pharmaceutical market and have a combined market value in excess of $182 billion
